Ohta Kiminori, Goto Tokuhito, Fijii Shinya, Suzuki Tomoharu, Ohta Shigeru, Endo Yasuyuki
Faculty of Pharmaceutical Sciences, Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.
Bioorg Med Chem. 2008 Sep 1;16(17):8022-8. doi: 10.1016/j.bmc.2008.07.055. Epub 2008 Jul 24.
We previously developed carborane-containing potent AR antagonists, BA321 and BA341, on the basis of our hypothesis that the carborane cage would be an excellent hydrophobic pharmacophore in place of steroidal C and D rings. As an extension of that work, we designed and synthesized carborane-containing AR antagonist candidates with a pyridine ring. Compound 6b, which has a pyridine ring directly bound to the p-carborane cage at the 3-position, exhibited potent AR-antagonistic activity in transcriptional activation assay using NIH3T3 cells transfected with a hAR-expression plasmid. In addition, it showed more potent antiandrogenic activity than that of the well-known antiandrogen flutamide and comparable activity to that of (R)-bicalutamide in SC-3 cell proliferation assay.
我们之前基于碳硼烷笼可作为取代甾体C环和D环的优良疏水药效基团这一假设,开发了含碳硼烷的强效雄激素受体(AR)拮抗剂BA321和BA341。作为该项工作的拓展,我们设计并合成了含吡啶环的含碳硼烷AR拮抗剂候选物。化合物6b在3位具有直接与对碳硼烷笼相连的吡啶环,在用转染了人AR表达质粒的NIH3T3细胞进行的转录激活试验中表现出强效的AR拮抗活性。此外,在SC-3细胞增殖试验中,它显示出比著名的抗雄激素药物氟他胺更强的抗雄激素活性,且与(R)-比卡鲁胺活性相当。